Ubs Group Ag Harpoon Therapeutics, Inc. Transaction History

Ubs Group Ag

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.55 - $0.82 $330 - $491	600 Added 23.6%	3,142 $2,000
Q4 2022 Feb 08, 2023	BUY	$0.6 - $1.41 $18 - $43	31 Added 1.23%	2,542 $1,000
Q3 2022 Nov 10, 2022	BUY	$0.94 - $2.56 $1,762 - $4,800	1,875 Added 294.81%	2,511 $2,000
Q2 2022 Aug 10, 2022	SELL	$1.78 - $5.02 $4,389 - $12,379	-2,466 Reduced 79.5%	636 $1,000
Q1 2022 May 16, 2022	SELL	$3.54 - $8.08 $16,829 - $38,412	-4,754 Reduced 60.51%	3,102 $15,000
Q4 2021 Feb 14, 2022	BUY	$5.69 - $7.83 $42,106 - $57,942	7,400 Added 1622.81%	7,856 $59,000
Q3 2021 Nov 15, 2021	SELL	$7.88 - $14.0 $50,550 - $89,810	-6,415 Reduced 93.36%	456 $4,000
Q2 2021 Aug 13, 2021	BUY	$13.81 - $23.25 $84,765 - $142,708	6,138 Added 837.38%	6,871 $96,000
Q1 2021 May 12, 2021	BUY	$17.65 - $24.16 $12,602 - $17,250	714 Added 3757.89%	733 $15,000
Q4 2020 Feb 11, 2021	SELL	$12.83 - $17.84 $40,093 - $55,750	-3,125 Reduced 99.4%	19 $0
Q3 2020 Nov 12, 2020	SELL	$11.01 - $18.52 $40,252 - $67,709	-3,656 Reduced 53.76%	3,144 $53,000
Q2 2020 Jul 31, 2020	SELL	$11.11 - $24.72 $11,243 - $25,016	-1,012 Reduced 12.95%	6,800 $113,000
Q1 2020 May 01, 2020	SELL	$10.74 - $16.32 $60,627 - $92,126	-5,645 Reduced 41.95%	7,812 $91,000
Q4 2019 Feb 14, 2020	BUY	$12.94 - $20.58 $100,453 - $159,762	7,763 Added 136.34%	13,457 $199,000
Q3 2019 Nov 14, 2019	BUY	$10.93 - $17.47 $50,627 - $80,921	4,632 Added 436.16%	5,694 $78,000
Q2 2019 Aug 14, 2019	BUY	$10.0 - $13.03 $10,620 - $13,837	1,062 New	1,062 $14,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.